Narcolepsy Trial, Recruiting (NCT06279247)

Narcolepsy Trial, Recruiting NCT06279247 Sponsor: Qilu Hospital of Shandong University Condition: Narcolepsy

Printed from Voxsanity (voxsanity.com.au) — NCT06279247 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Narcolepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You may be eligible if you have been diagnosed with a sleep disorder according to the standard international guidelines for diagnosing sleep conditions (called ICSD-3).

Who may not be able to join:

People whose excessive sleepiness is caused by shift work, not getting enough sleep, or other disruptions to their sleep schedule
People whose excessive sleepiness is caused by drug or substance misuse
People who have a neurological or mental health condition, such as Parkinson's disease, Alzheimer's disease, or similar disorders
People who have serious health conditions affecting the heart, lungs, liver, kidneys, blood, or hormonal system, or who have had a recent infection
People who have taken sleeping pills, sedatives, antidepressants, lithium, or certain other medications within the two weeks before being assessed for the trial
People who are unable to take part in two specific sleep tests — an overnight sleep study (PSG) and a daytime nap test (MSLT) — for any reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 18560088921

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06279247

Sponsor: Qilu Hospital of Shandong University

Phase: Not Applicable

Status: Recruiting

Condition: Narcolepsy

Trial contact: 18560088921

More information: https://clinicaltrials.gov/study/NCT06279247

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You may be eligible if you have been diagnosed with a sleep disorder according to the standard international guidelines for diagnosing sleep conditions (called ICSD-3).

Who may not be able to join:

People whose excessive sleepiness is caused by shift work, not getting enough sleep, or other disruptions to their sleep schedule
People whose excessive sleepiness is caused by drug or substance misuse
People who have a neurological or mental health condition, such as Parkinson's disease, Alzheimer's disease, or similar disorders
People who have serious health conditions affecting the heart, lungs, liver, kidneys, blood, or hormonal system, or who have had a recent infection
People who have taken sleeping pills, sedatives, antidepressants, lithium, or certain other medications within the two weeks before being assessed for the trial
People who are unable to take part in two specific sleep tests — an overnight sleep study (PSG) and a daytime nap test (MSLT) — for any reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Qilu Hospital of Shandong University

Registry

ClinicalTrials.gov

Start date

1 September 2022

Est. completion

26 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

To screen potential molecular markers related to the biological characteristics and prognosis of narcolepsy.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov